OR WAIT null SECS
July 02, 2013
Pharma and biotech companies, with the rest of the health care industry, must face change.
June 02, 2013
Ranbaxy's $500 million settlement for producing adulterated drugs and fradulent data provides a cautionary tale for patients, FDA, and drug manufacturers.
May 02, 2013
Wanted: Article contributions on drug and process development topics.
March 02, 2013
QbD paradigm advances process understanding in development and manufacturing.
January 02, 2013
From time to time, it's important to take stock of the industry from both a retrospective and prospective point of view.
November 02, 2012
Global tactics that incorporate online technologies and social media are reshaping disease response.
October 02, 2012
Will the next US President support the backbone of our industry?
August 02, 2012
Manufacturers willing to report bad news about the supply can help reverse the shortage trend.
July 02, 2012
Taking time to appreciate the industry's greatest achievements will inspire growth ahead.
June 02, 2012
BIO is calling for a more patient-centric approach to user-fee reauthorization.